CCI approves the proposal of Tau Investment to acquire shares in J B Chemicals
August 26, 2020
New Delhi: The Competition Commission of India (CCI) has approved the proposal of Tau Investment to acquire shares in J B Chemicals. The proposed combination envisages acquisition of acquisition of up to 64.90% of share capital of J B Chemicals & Pharmaceuticals Limited by Tau Investment Holdings Pte. Ltd. (Tau Investment).
Tau Investment is a company incorporated in Singapore. It is an indirect wholly owned subsidiary of KKR Asian Fund III L.P. It is an affiliate of funds, vehicles and/or entities managed and/or advised by Kohlberg Kravis Roberts & Co. L.P., which is an indirect subsidiary of KKR & Co. Inc.
J B Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company, headquartered in Mumbai, Maharashtra. Majority of its chemical business and CSR activities are located in Gujarat area, especially in Bharuch. It is listed on BSE Limited and the National Stock Exchange of India Limited.
Recent Stories
- RIL reports Rs 21,243-crore profit for Q4 FY2023-24; EBITDA up 16.1%
- AIMIM to not contest in Lok Sabha elections from Gujarat
- 35 including 10 minors take Deeksha in Ahmedabad embracing monkhood
- Firing at Salman's House: Mumbai Crime Branch searches for gun in Surat's Tapi River
- Vehicles with White LED Headlights to face action; Ahmedabad RTO begins drive
- Surat Lok Sabha seat BJP candidate wins unopposed
- BJP leaders in talks with Kshatriya community members